Basics Korro Bio, Inc. IPO Date: October 4, 2019 Sector: Healthcare Industry: Biotech Market Cap: $101.42M Activated in VL: True Average Daily Range Avg Daily Range: $0.92 | 4.39% Avg Daily Range (30 D): $1.06 | 6.90% Avg Daily Range (90 D): $1.14 | 5.73% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .09M Trade Size Avg Trade Size (Sh.): 136 Avg Trade Size (Sh.) (30 D): 76 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 269 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $1.66M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.76M Avg Closing Trade (30 D): $.61M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 142.45K     News Mar 14, 2025 @ 12:00 PM KRRO-110 Receives Orphan Drug Designation from U.S... Source: N/A Nov 8, 2024 @ 7:34 AM 4 Biotech Stocks With AI, Machine Learning Prowess... Source: Professor Ari Zoldan Sep 19, 2024 @ 10:50 AM Novo Nordisk Just Took a $530 Million Step Onto Mo... Source: The Motley Fool May 20, 2024 @ 6:30 PM Korro Presents Additional Preclinical Data for KRR... Source: Korro Bio, Inc. May 14, 2024 @ 8:01 PM Korro Reports First Quarter 2024 Financial Results... Source: Korro Bio, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-9.44 $-2.49 $-2.26 Diluted EPS $-9.44 $-2.49 $-2.26 Revenue $ 4.82M $ 2.55M $ 2.27M Gross Profit $ $ $ Net Income / Loss $ -87.41M $ -23.39M $ -21.2M Operating Income / Loss $ -95.48M $ -25.02M $ -23.04M Cost of Revenue $ $ $ Net Cash Flow $ -78.21M $ 8.5M $ -9.33M PE Ratio